BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 12930376)

  • 1. In vitro co-stimulation with anti-CD28 synergizes with IL-12 in the generation of T cell immune responses to leukaemic cells; a strategy for ex-vivo generation of CTL for immunotherapy.
    Orleans-Lindsay JK; Deru A; Craig JI; Prentice HG; Lowdell MW
    Clin Exp Immunol; 2003 Sep; 133(3):467-75. PubMed ID: 12930376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Restimulation of tumour-specific immunity in a patient with AML following injection with B7-1 positive autologous blasts.
    Hicks C; Cheung C; Lindeman R
    Leuk Res; 2003 Nov; 27(11):1051-61. PubMed ID: 12859998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential graft-versus-leukaemia effect by CD28 and CD40 co-stimulatory blockade after graft-versus-host disease prophylaxis.
    Ohata J; Sakurai J; Saito K; Tani K; Asano S; Azuma M
    Clin Exp Immunol; 2002 Jul; 129(1):61-8. PubMed ID: 12100023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of experimental blood stage malaria through blockade of the B7/CD28 T-cell costimulatory pathway.
    Taylor-Robinson AW; Smith EC
    Immunology; 1999 Mar; 96(3):498-504. PubMed ID: 10233733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of B7 costimulation by murine acute myeloid leukemia in the generation and function of a CD8+ T-cell line with potent in vivo graft-versus-leukemia properties.
    Boyer MW; Vallera DA; Taylor PA; Gray GS; Katsanis E; Gorden K; Orchard PJ; Blazar BR
    Blood; 1997 May; 89(9):3477-85. PubMed ID: 9129056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD28 ligands CD80 (B7-1) and CD86 (B7-2) induce long-term autocrine growth of CD4+ T cells and induce similar patterns of cytokine secretion in vitro.
    Levine BL; Ueda Y; Craighead N; Huang ML; June CH
    Int Immunol; 1995 Jun; 7(6):891-904. PubMed ID: 7577797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ex vivo culture with interleukin (IL)-12 improves CD8(+) T-cell adoptive immunotherapy for murine leukemia independent of IL-18 or IFN-gamma but requires perforin.
    Macgregor JN; Li Q; Chang AE; Braun TM; Hughes DP; McDonagh KT
    Cancer Res; 2006 May; 66(9):4913-21. PubMed ID: 16651448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of CD80/B7-1 and CD86/B7-2 molecule expression in human primary acute myeloid leukemia and their role in allogenic immune recognition.
    Costello RT; Mallet F; Sainty D; Maraninchi D; Gastaut JA; Olive D
    Eur J Immunol; 1998 Jan; 28(1):90-103. PubMed ID: 9485189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential requirements for co-stimulatory signals from B7 family members by resting versus recently activated memory T cells towards soluble recall antigens.
    Yi-qun Z; Joost van Neerven RJ; Kasran A; de Boer M; Ceuppens JL
    Int Immunol; 1996 Jan; 8(1):37-44. PubMed ID: 8671587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential expression of B7 co-stimulatory molecules by astrocytes correlates with T cell activation and cytokine production.
    Soos JM; Ashley TA; Morrow J; Patarroyo JC; Szente BE; Zamvil SS
    Int Immunol; 1999 Jul; 11(7):1169-79. PubMed ID: 10383950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin 12 synergizes with B7/CD28 interaction in inducing efficient proliferation and cytokine production of human T cells.
    Kubin M; Kamoun M; Trinchieri G
    J Exp Med; 1994 Jul; 180(1):211-22. PubMed ID: 7516408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-7 permits Th1/Tc1 maturation and promotes ex vivo expansion of cord blood T cells: a critical step toward adoptive immunotherapy after cord blood transplantation.
    Davis CC; Marti LC; Sempowski GD; Jeyaraj DA; Szabolcs P
    Cancer Res; 2010 Jul; 70(13):5249-58. PubMed ID: 20530666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequential modulation of growth factors: a novel strategy for adoptive immunotherapy of acute myeloid leukemia.
    Zhong RK; Rassenti LZ; Kipps TJ; Chen J; Law P; Yu JF; Ball ED
    Biol Blood Marrow Transplant; 2002; 8(10):557-68. PubMed ID: 12434951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient-individualized CD8⁺ cytolytic T-cell therapy effectively combats minimal residual leukemia in immunodeficient mice.
    Distler E; Albrecht J; Brunk A; Khan S; Schnürer E; Frey M; Mottok A; Jordán-Garrote AL; Brede C; Beilhack A; Mades A; Tomsitz D; Theobald M; Herr W; Hartwig UF
    Int J Cancer; 2016 Mar; 138(5):1256-68. PubMed ID: 26376181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different cytokine and stimulation conditions influence the expansion and immune phenotype of third-generation chimeric antigen receptor T cells specific for tumor antigen GD2.
    Gargett T; Brown MP
    Cytotherapy; 2015 Apr; 17(4):487-95. PubMed ID: 25573334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rejection of syngeneic colon carcinoma by CTLs expressing single-chain antibody receptors codelivering CD28 costimulation.
    Haynes NM; Trapani JA; Teng MW; Jackson JT; Cerruti L; Jane SM; Kershaw MH; Smyth MJ; Darcy PK
    J Immunol; 2002 Nov; 169(10):5780-6. PubMed ID: 12421958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 4-1BB is superior to CD28 costimulation for generating CD8+ cytotoxic lymphocytes for adoptive immunotherapy.
    Zhang H; Snyder KM; Suhoski MM; Maus MV; Kapoor V; June CH; Mackall CL
    J Immunol; 2007 Oct; 179(7):4910-8. PubMed ID: 17878391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Priming of a novel subset of CD28+ rapidly expanding high-avidity effector memory CTL by post maturation electroporation-CD40L dendritic cells is IL-12 dependent.
    DeBenedette MA; Calderhead DM; Ketteringham H; Gamble AH; Horvatinovich JM; Tcherepanova IY; Nicolette CA; Healey DG
    J Immunol; 2008 Oct; 181(8):5296-305. PubMed ID: 18832685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single-chain antigen recognition receptors that costimulate potent rejection of established experimental tumors.
    Haynes NM; Trapani JA; Teng MW; Jackson JT; Cerruti L; Jane SM; Kershaw MH; Smyth MJ; Darcy PK
    Blood; 2002 Nov; 100(9):3155-63. PubMed ID: 12384413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. B7-CD28 interaction is a late acting co-stimulatory signal for human T cell responses.
    Zhang YQ; Joost van Neerven RJ; Van Gool SW; Coorevits L; de Boer M; Ceuppens JL
    Int Immunol; 1997 Aug; 9(8):1095-102. PubMed ID: 9263006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.